stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Gratuito - Play StoreApp Store
InstallareInstallare
logo
Viridian Therapeutics IncVRDN
$29.0615.53%3.905
Dopo l'orario di chiusura: 29.72+0.66 +2.29%

Viridian Therapeutics Inc (VRDN)

Date: 2026-11-04 16:00O: 28.27H: 29.74L: 25.07C: 29.06Vol: 11.17M
Precedente Chiudi:
$25.15
Aprire:
$28.27
Volume 24 ore:
11,165,399
Volume relativo:
3.64
Capitalizzazione di mercato:
$3.29B
Reddito:
$70.92M
Utile/perdita netta:
-$342.21M
Rapporto P/E:
-
EPS:
-$3.76
Flusso di cassa netto:
-$304.30M
1W Prestazione:
+19.72%
1M Prestazione:
+49.77%
6M Prestazione:
+106.65%
1Y Prestazione:
+28.85%
Intervallo 1D:
$25.07$29.74
Intervallo di 1 settimana:
$23.97$29.74
Portata 52W:
$13.18$34.29

Profilo aziendale di Viridian Therapeutics Inc (VRDN)

Nome
Viridian Therapeutics Inc
Settore
Healthcare
Industria
Biotechnology
Telefono
617.272.4600
Indirizzo
221 CRESCENT STREET, WALTHAM, USA
Dipendente
252
X
-
Prossima data di guadagno
null
Ultimi documenti SEC
SEC
Discussioni di VRDN su X
X

 

Cap. di mercato

 

Reddito

 

Reddito netto

 

Flusso di cassa

 

EPS

 

Viridian Therapeutics Inc Azioni (VRDN) Upgrade e downgrade

DataAzioneAnalistaModifica della valutazione
2026-06-29AggiornamentoWells FargoEqual Weight → Overweight
2025-12-10ReiteratoWedbushOutperform
2025-12-03IniziatoWilliam BlairOutperform
2025-11-24IniziatoTruistBuy

Viridian Therapeutics Inc Azioni (VRDN) Dati Finanziari

PeriodoAndamentoFY 2025FY 2024FY 2023FY 2022FY 2021
Data di fine periodo2025-12-312024-12-312023-12-312022-12-312021-12-31
Revenue USD (M)70.850.300.311.772.96
Operating expenses USD (M)434.24299.34254.76136.0882.69
Operating income USD (M)-363.40-299.04-254.45-134.30-79.73
Income before tax USD (M)--0.311.772.96
Income tax expense USD (M)0.00----
Net income USD (M)-342.60-269.95-237.73-129.87-79.41
Basic EPS USD/shares---5.31-4.05-6.66
Diluted EPS USD/shares---5.31-4.05-6.66
Basic weighted shares shares (M)--44.7632.0911.92
Diluted weighted shares shares (M)--44.7632.0911.92
Selling, general and administrative USD (M)95.32----

Viridian Therapeutics Inc Azioni (VRDN) insider trading

  • Chief Legal Officer
    Transazione
    Option Exercise
    Costo
    $14.41
    #Azioni
    10,000
    Valore ($)
    144,100
    #Azioni Totale
    10,000
  • Chief Legal Officer
    Transazione
    Sale
    Costo
    $24.50
    #Azioni
    14,212
    Valore ($)
    348,194
    #Azioni Totale
    0
  • Officer
    Transazione
    Proposed Sale
    Costo
    $24.50
    #Azioni
    14,212
    Valore ($)
    348,194
    #Azioni Totale
    0
  • Chief Medical Officer
    Transazione
    Option Exercise
    Costo
    $13.21
    #Azioni
    40,000
    Valore ($)
    528,400
    #Azioni Totale
    40,000
  • Director
    Transazione
    Buy
    Costo
    $17.00
    #Azioni
    1,176,470
    Valore ($)
    19,999,990
    #Azioni Totale
    5,090,928
  • Officer
    Transazione
    Proposed Sale
    Costo
    $30.19
    #Azioni
    3,048
    Valore ($)
    92,004
    #Azioni Totale
    0
  • Officer
    Transazione
    Proposed Sale
    Costo
    $30.19
    #Azioni
    1,675
    Valore ($)
    50,560
    #Azioni Totale
    0
  • Harmon SethMar 04 '26
    Officer
    Transazione
    Proposed Sale
    Costo
    $30.19
    #Azioni
    2,031
    Valore ($)
    61,306
    #Azioni Totale
    0
  • Officer
    Transazione
    Proposed Sale
    Costo
    $30.19
    #Azioni
    7,408
    Valore ($)
    223,610
    #Azioni Totale
    0
  • Chief Legal Officer
    Transazione
    Sale
    Costo
    $31.16
    #Azioni
    2,272
    Valore ($)
    70,796
    #Azioni Totale
    0
Commercio internoRelazioneDataTransazioneCosto#AzioniValore ($)#Azioni Totale
Tousignant JenniferChief Legal OfficerAug 19 '26Option Exercise$14.4110,000144,10010,000
Tousignant JenniferChief Legal OfficerAug 19 '26Sale$24.5014,212348,1940
Tousignant JenniferOfficerAug 19 '26Proposed Sale$24.5014,212348,1940
Tripuraneni RadhikaChief Medical OfficerAug 14 '26Option Exercise$13.2140,000528,40040,000
Fairmount Funds Management LLCDirectorMay 11 '26Buy$17.001,176,47019,999,9905,090,928
Beetham Thomas W.OfficerMar 04 '26Proposed Sale$30.193,04892,0040
Tousignant JenniferOfficerMar 04 '26Proposed Sale$30.191,67550,5600
Harmon SethOfficerMar 04 '26Proposed Sale$30.192,03161,3060
Mahoney Stephen F.OfficerMar 04 '26Proposed Sale$30.197,408223,6100
Tousignant JenniferChief Legal OfficerDec 31 '25Sale$31.162,27270,7960

Viridian Therapeutics Inc Borsa (VRDN) Ultime notizie

Nov 03, 2026
Nov 03, 2026
Sep 22, 2026
Sep 22, 2026
Sep 08, 2026
Sep 08, 2026
Sep 03, 2026
Sep 03, 2026
Sep 02, 2026
Sep 02, 2026
Sep 02, 2026
Sep 02, 2026
Sep 02, 2026
Sep 02, 2026
Aug 31, 2026
Aug 31, 2026
Aug 21, 2026
Aug 21, 2026
Aug 20, 2026
Aug 20, 2026
Aug 20, 2026
Aug 20, 2026
Aug 20, 2026
Aug 20, 2026
Aug 20, 2026
Aug 20, 2026
Aug 20, 2026
Aug 20, 2026
Aug 20, 2026
Aug 20, 2026
Aug 20, 2026
Aug 20, 2026
Aug 20, 2026
Aug 20, 2026
Aug 20, 2026
Aug 20, 2026
Aug 20, 2026
Aug 20, 2026
Aug 20, 2026
Aug 20, 2026
Aug 20, 2026
Aug 20, 2026
Aug 19, 2026
Aug 19, 2026
Aug 19, 2026
Aug 19, 2026
Aug 18, 2026
Aug 18, 2026
Aug 18, 2026
Aug 18, 2026
Aug 18, 2026
Aug 18, 2026
Aug 18, 2026
Aug 18, 2026
Aug 14, 2026
Aug 14, 2026
Aug 14, 2026
Aug 14, 2026
Aug 14, 2026
Aug 14, 2026
Aug 14, 2026
Aug 14, 2026
Aug 14, 2026
Aug 14, 2026
Aug 13, 2026
Aug 13, 2026
Aug 13, 2026
Aug 13, 2026
Aug 13, 2026
Aug 13, 2026
Aug 13, 2026
Aug 13, 2026
Aug 13, 2026
Aug 13, 2026
Aug 12, 2026
Aug 12, 2026
Aug 12, 2026
Aug 12, 2026
Aug 12, 2026
Aug 12, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 09, 2026
Aug 09, 2026
Aug 08, 2026
Aug 08, 2026
Aug 08, 2026
Aug 08, 2026
Aug 08, 2026
Aug 08, 2026
Aug 07, 2026
Aug 07, 2026

Simile a VRDN